Medtech grants in Norway

Between cycles

Supports EIC beneficiaries' participation in major trade fairs across the EU, MENA and the US.

Between cycles

Funds early-stage deep tech startups developing solutions at TRL 4-5 in collaboration with industry partners through a 4-month co-creation programme.

Between cycles

Supports international consortia so small companies can turn joint innovation into export-ready products.

Between cycles

Offers market-feasibility support for small companies exploring non-European markets through Europe-wide innovation networks.

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Funds early clinical trials of therapies built from the molecules cells secrete rather than the cells themselves, aiming for an off-the-shelf alternative to cell therapy.

Closed

Pays cash prizes to teams that build and validate generative AI solutions for enhancing clinical datasets or generating automatic test cases from crash databases.

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

Closed

Funds wearable devices and apps, paired with behavioural coaching, that help 12-to-25-year-olds build habits that prevent the most common non-cancer chronic diseases later in life.

Closed

Pays 200,000 euros to study bioengineering business ideas that use microgravity.

Closed

Funds small, SME-majority consortia running an early-phase clinical trial to move a biotech therapy, from antibodies to RNA therapies, from the lab towards the market.

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.

Funds public-private research that connects fragmented health R&I efforts into shared tools, data, platforms and manufacturing processes.

Funds public-private research on interoperable health data and AI analytics that speed up diagnosis, treatment and personalised care.

Closed

Funds three lead projects, worth up to EUR 15 million each, that each run a multi-stage generative-AI competition in aerospace, pharma or telecom — with EUR 250,000 grants to the top 20 entrants and EUR 2 million grants to the final four.

Closed

Funds research and low-carbon medical technology that cuts the health sector's own emissions while making healthcare systems and communities more resilient to climate change.

Funds one consortium to build a scannable digital-label standard that replaces cluttered printed labelling on medical devices and diagnostics.

Closed

Funds one coordination project that pilots a digital, data-driven replacement for the paper-heavy conformity assessment process device makers use to get CE marking under the MDR and IVDR.

Closed

Awards EU deep-tech teams up to €2.5 million in lump-sum grants across two stages.

Closed

Pays the existing EU Personalised Medicine partnership to bring in new partners and additional activities under an amended grant agreement.

Closed

Funds research teams that use gene and epigenome editing to engineer safer, more effective off-the-shelf cell therapies for one chosen disease area.

Funds coordination projects that scale up validated digital health and AI tools across national or sub-regional health systems in sub-Saharan Africa.